BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 33115218)

  • 1. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
    Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
    Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?
    O'Connor E; Teh J; Kamat AM; Lawrentschuk N
    Future Oncol; 2020 Jul; 16(19):1323-1325. PubMed ID: 32406253
    [No Abstract]   [Full Text] [Related]  

  • 5. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
    Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL
    Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
    Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
    Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
    Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
    J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in possible effects of BCG vaccine on the prevention of SARS-CoV-2 infection: An update].
    Huang W; Liu T; Feng G; Wang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1044-1048. PubMed ID: 33210600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Routine Infant BCG Vaccination on COVID-19.
    Kinoshita M; Tanaka M
    J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses.
    Hensel J; McAndrews KM; McGrail DJ; Dowlatshahi DP; LeBleu VS; Kalluri R
    Sci Rep; 2020 Oct; 10(1):18377. PubMed ID: 33110184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed.
    Schaaf HS; du Preez K; Kruger M; Solomons R; Taljaard JJ; Rabie H; Seddon JA; Cotton MF; Tebruegge M; Curtis N; Hesseling AC
    Int J Tuberc Lung Dis; 2020 Jul; 24(7):732-734. PubMed ID: 32718410
    [No Abstract]   [Full Text] [Related]  

  • 12. BCG-induced trained immunity: can it offer protection against COVID-19?
    O'Neill LAJ; Netea MG
    Nat Rev Immunol; 2020 Jun; 20(6):335-337. PubMed ID: 32393823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG versus COVID-19?
    Kantor IN
    Medicina (B Aires); 2020; 80(3):292-294. PubMed ID: 32442946
    [No Abstract]   [Full Text] [Related]  

  • 14. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
    Tomita Y; Sato R; Ikeda T; Sakagami T
    Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy.
    Koti M; Morales A; Graham CH; Siemens DR
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32636240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
    Sharma AR; Batra G; Kumar M; Mishra A; Singla R; Singh A; Singh RS; Medhi B
    Allergol Immunopathol (Madr); 2020; 48(5):507-517. PubMed ID: 32653224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
    Gupta PK
    Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
    Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM
    Front Immunol; 2020; 11():970. PubMed ID: 32574258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
    Vashishtha VM
    Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
    Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.